title: [Alpha-1 inhibition. Clinical studies of the efficacy and tolerability of Alpress LP in mild to moderate essential hypertension].
abstract: Alpress LP allows a continuous flow of prazosin, thanks to its new galenic form. This implies a better efficacy and less side-effects in the treatment of hypertension. Besides, prazosin being known for its favourable effect on hypercholesterolemia, Alpress LP was studied in this respect. In each of the three studies detailed thereafter, concerning hypertensive patients, proof was made of the efficacy and the good tolerance of Alpress LP, as compared to reference therapeutics given in hypercholesterolemia.
authors.affiliation: Service de Cardiologie, Hôpital de La Timone, Marseille.
authors.forename: R
authors.initials: R
authors.lastname: Luccioni
authors.forename: Y
authors.initials: Y
authors.lastname: Chestier
authors.forename: M
authors.initials: M
authors.lastname: Galinier
authors.forename: B
authors.initials: B
authors.lastname: Charbonnier
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004656:Enalapril / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011224:Prazosin / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D003692:Delayed-Action Preparations; D004656:Enalapril; D011224:Prazosin
vernacular_title: L'inhibition alpha 1. Etudes cliniques de l'efficacité et de la tolérance dans l'hypertension artérielle essentielle légère à modérée d'Alpress LP.